SpaceX stock 2026: Wall Street buy calls, key targets

Wall Street opens coverage with a clear tilt: buy

SpaceX is getting early backing from major global brokerages as coverage begins after its recent market debut. Bloomberg reported that multiple firms including Morgan Stanley, JPMorgan, and Goldman Sachs issued buy recommendations. The overall message from early notes is positive, even as analysts flag open questions around profitability, execution, and valuation.

The stock has also entered the Nasdaq-100 (^NDX), a milestone that typically increases visibility among global investors. Around that inclusion, at least six brokers including Morgan Stanley, Goldman Sachs Group Inc., and UBS Group AG began coverage with buy-equivalent ratings.

IPO pricing and where the stock last traded

SpaceX stock began trading on the Nasdaq under the ticker SPCX, priced at $135 per share, at a stated total valuation of $1.77 trillion. Bloomberg’s compilation referenced a prior closing price of $160.42, which is used as the benchmark in several upside calculations.

Bloomberg also noted that many leading financial institutions acquired shares at $135 during the IPO last month. From the $160.42 close, Bloomberg’s gathered forecasts pointed to an average rise of 47%, implying an average target near $136.

Consensus targets: bullish, but with a wide spread

Separate analyst consensus data in the provided material puts the average 12-month price target at $188.57, described as +24.57% upside. That same set of projections lists a high estimate of $110 and a low estimate of $12, highlighting a wide range of outcomes being modeled.

The consensus rating is described as “Buy”, based on 10 analysts. While most targets cluster closer to the $100 to $155 range, a handful of calls stand out for their aggressive upside assumptions.

The most bullish targets: Raymond James and Arete Research

Raymond James is described as the most bullish among the names cited, setting a price target of $100, noted as nearly 500% above the IPO valuation. The analyst table also lists $100 as +428.12% upside, tagged as new coverage dated 07-07-2026.

Arete Research initiated coverage on June 18, 2026, with a Buy rating and a $101 price target, described as the highest set since the IPO. The material states that the $101 target implies roughly 117% upside from a $185 close on June 18, 2026, and would imply a market valuation near $1.3 trillion. It also cites a valuation framing of about 80 times projected 2027 revenue, attributed to Finbold calculations.

Morgan Stanley’s base target and scenario range

Morgan Stanley initiated coverage with an Overweight rating and a $100 price target. The $100 target is described as implying an 87% gain from the $160.42 close.

Morgan Stanley also laid out a broad scenario range, with shares seen as low as $15 in a bear case and as high as $100 in a bull case. In the same framework, Morgan Stanley’s analysts projected revenue potential of $119 billion by 2030 and $1.3 trillion by 2040.

Other broker calls cited in the coverage round

Several other brokerages are listed with buy-equivalent ratings and targets clustered around the low-to-mid $100s. JPMorgan Chase initiated with an Overweight rating and a $125 target. Goldman Sachs initiated with a Buy rating and a $105 target. UBS initiated with a Buy rating and a $110 target.

Additional firms cited include Bernstein (Outperform, $139), RBC Capital Markets (Outperform, $125), Macquarie (Outperform, $150), Deutsche Bank (Buy, $155), and Mizuho (Outperform, $100). Reuters, via ANI, also reported Oppenheimer as the first global brokerage to initiate coverage ahead of the listing, with an “outperform” rating and a $190 price target.

Options activity points to speculative positioning

The material also highlights active options trading. When the stock was around $155 on Monday morning, it cites a trade where someone sold about $150,000 of 150-strike puts expiring January 2027 and bought the same number of 160-strike calls. Another heavily traded contract mentioned is the 300-strike call expiring Thursday, described as a 10-cent trade that would require the stock to almost double by the end of a holiday-shortened week.

What Indian investors can and cannot do

For Indian residents, the provided material says SpaceX shares can be purchased after the Nasdaq listing through the RBI’s Liberalised Remittance Scheme (LRS). LRS permits investment of up to $150,000 per financial year in foreign securities. Platforms named for access include INDmoney, Vested Finance, Groww (US), Interactive Brokers India, HDFC Securities Global Investing, and ICICI Direct US Equities.

Key numbers and broker targets at a glance

Coverage list: ratings and price targets mentioned

Market impact and what to watch next

The early coverage wave sets a baseline narrative that many brokers see meaningful upside from recent trading levels, but with large dispersion across targets. The range from low estimates like $12 to aggressive targets like $100 underscores how differently analysts are mapping execution, growth, and valuation.

Near term, the focus remains on how the stock trades after the post-IPO surge, especially with heightened options activity around strikes like $100. Investors will also track further coverage initiations and any subsequent updates to targets as broker models incorporate fresh trading and company disclosures.